alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 65, Number 214 (Friday, November 3, 2000)]
[Notices]
[Page 66254]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-28349]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of 
Meeting; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of October 19, 2000 (65 FR 
62722). The notice announced a meeting of the Dermatologic and 
Ophthalmic Drugs Advisory Committee, which was scheduled for November 
16, 2000. The document was published with an error. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Anita Prout, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-5503.

SUPPLEMENTARY INFORMATION: In FR Doc. 00-26787, appearing on page 62722 
in the Federal Register of Thursday, October 19, 2000, the following 
correction is made:
    1. On page 62722, in the first column, under the ``Location'' 
caption, ``Holiday Inn, Grand Ballroom, Two Montgomery Village Ave., 
Gaithersburg, MD.'' is corrected to read ``CDER Advisory Committee, 
conference room 1066, 5630 Fishers Lane, Rockville, MD.''

    Dated: October 31, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-28349 Filed 11-01-00; 2:45 pm]
BILLING CODE 4160-01-F
Case 3:22-cr-00131-S   Document 33   Filed 02/08/23    Page 1 of 1   PageID 56
**EXHIBIT 10.2**

** **

**Summary of Executive Bonus Plan**

 

On February 9, 2005, the Compensation Committeeof our Board of Directors adopted an executive bonus plan effective beginning January 1,2005. The executive bonus plan was amended by the Compensation Committeeeffective January 1, 2008. Under the amended executive bonus plan, oureligible executive officers are eligible to receive (i) a quarterly bonusof up to a specified percentage of any amount by which the Company’sconsolidated adjusted pre-tax income for such quarter exceeds the Company’sconsolidated adjusted pre-tax income for the same quarter of the prior year and(ii) an annual bonus of up to a specified percentage of any amount bywhich the Company’s consolidated adjusted pre-tax income for the fiscal yearexceeds the Company’s consolidated adjusted pre-tax income for the previousfiscal year. For purposes of the executive bonus plan, “adjusted income” isdefined as the Company’s consolidated pre-tax income for the applicable quarteror annual period, less certain costs that are excluded from the calculation ona quarterly or annual basis by the Compensation Committee in its solediscretion.

 

The maximum participation percentage for our executiveofficers currently eligible to participate in the plan is as follows:

 
| **PLAN PARTICIPANT**                                                 | Maximum  Percentage  Participation In  Quarterly Bonus | Maximum  Percentage  Participation In  Annual Bonus |
|----------------------------------------------------------------------|--------------------------------------------------------|-----------------------------------------------------|
| Frank F. Khulusi  President and Chief Executive Officer              |  

2.85%

                                   |  

0.95%

                                |
| Brandon H. LaVerne  Chief Financial Officer                          |  

0.90%

                                   |  

0.30%

                                |
| Kristin M. Rogers  Executive Vice President—Sales and Marketing |  

0.90%

                                   |  

0.30%

                                |
| Daniel J. DeVries  Executive Vice President—Consumer            |  

0.90%

                                   |  

0.30%

                                |

 

The Compensation Committee may amend the foregoingpercentages from time to time in its sole discretion. In addition, theCompensation Committee may in its sole discretion reduce the amounts that wouldotherwise be payable to any participant for any period (including a completeelimination of all amounts identified under the table above for the period). Anysuch reduction may be based on quantitative or qualitative factors determinedin the discretion of the Compensation Committee.

 

----
[Federal Register Volume 65, Number 214 (Friday, November 3, 2000)]
[Proposed Rules]
[Pages 66222-66223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-28305]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration

50 CFR Part 648

[I.D. 091800K]


Mid-Atlantic Fishery Management Council; Public Hearings

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Cancellation of public hearings.

-----------------------------------------------------------------------

[[Page 66223]]

SUMMARY: NMFS announces the cancellation of two public hearings that 
had dates and locations yet to be determined by the Atlantic States 
Marine Fisheries Commission (ASMFC) and held in the states of 
Massachusetts and Rhode Island on the public hearing draft of Amendment 
13 to the Summer Flounder, Scup, and Black Sea Bass Fishery Management 
Plan. The intent to schedule these meetings was announced in the 
Federal Register on September 27, 2000.

FOR FURTHER INFORMATION CONTACT: Daniel T. Furlong, Executive Director 
of the Mid-Atlantic Fishery Management Council (Council), 302-674-2331, 
ext. 19, or John Dunnigan, Executive Director, ASMFC, 202-289-6400, 
ext. 304.

SUPPLEMENTARY INFORMATION: NMFS, the Council, and ASMFC jointly manage 
the summer flounder fishery off the Atlantic coast. An earlier notice, 
published in the Federal Register (65 FR 58035, September 27, 2000) 
announced four public hearings with specific locations and dates to 
gather public comments on draft Amendment 13. The same notice also 
advised the public that two additional hearings (one in Massachusetts 
and one in Rhode Island) would be held at locations and times to be 
determined by the ASMFC and announced later through another notice in 
the Federal Register. The ASMFC has decided not to hold these hearings.

    Dated: October 30, 2000.
Bruce C. Morehead,
Acting Director, Office of Sustainable Fisheries, National Marine 
Fisheries Service.
[FR Doc. 00-28305 Filed 11-2-00; 8:45 am]
BILLING CODE 3510-22-S
EXHIBIT 23.1

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statements on Form S-8 pertaining to the 1996 Incentive Stock Plan, the 1998
Employee Stock Purchase Plan, the 1998 Director Option Plan, the 1999 Nonstatutory Stock Option Plan of Abgenix, Inc. and the Canadian Employee Stock Purchase Plan, and the Registration
Statements on Form S-3 (Nos. 333-49858 and 333-89374) and in the related Prospectuses, of our report dated January 30, 2003, with respect to the
consolidated financial statements of Abgenix, Inc. included in the Annual Report (Form 10-K) for the year ended December 31, 2002.

|                                     |  | /s/ Ernst & Young LLP
|------------------------------------ |  | ---------------------
|Palo Alto, California
March 26, 2003 |  |                      

---

QuickLinks
#### The State of Ohio, Appellee, *v.*Markowitz, Appellant. 

(No. 28419

Decided January 15, 1941.)

*Mr. Frank T. Cullitan,*prosecuting attorney, *Mr. Néil W. McGill*and *Mr. John P. Butter,*for appellee.

*Mr. A. L. Kearns*and *Mr. Alfred A. Frost,*for appellant.

It is ordered and adjudged that said appeal as of right be, and the same hereby is, dismissed for the reason no debatable constitutional question is involved in said cause.

*Appeal dismissed.*

Weygandt, C. J., Turner, Williams, Matthias, Hart, Zimmerman and Bettman, JJ., concur.
From: Kyle Baker

- NOAA Federal [kyle.baker@noaa.gov]

Sent: Thursday, February 21, 2013 8:07 AM

To: Land, Eva

Cc: jon_hemming@fws.gov; Fortin, Kelly; Shepherd, Lorinda
Subject: Re: BA for New OCS Permit Applications Submitted to EPA

NMFS has not yet completed any consultations on lease sales or permits under the 2012

- 2017 lease plan. We just received a BA from BOEM and BSEE for lease sale actions under lease sales held through the year 2022. The EPA is a co

- action agency on this co nsultation. BOEM has determined that their current regulatory measures in place are sufficient until a new consultaiton is completed. I am uncertain how that determination effects permit application

submitted to the EPA under those lease sales. I reco mmend first conferring with your BOEM contacts since their is no current biological opinion looking forward. BOEM is working under the opinion prepared for the 2007

- 2012 lease plan until consultation is completed.

On Wed, Feb 20, 2013 at 4:30 PM, Land, Eva < Land.Eva@epa.gov > wrote:

Mr. Baker and Mr. Hemming:

The EPA Region 4 has received three additional Outer Continental Shelf permit applications from Statoil Gulf Services, Anadarko Petroleum Corpor ation, and Shell Offshore Inc. These applications are covered by BOEM lease sales and the following Environmental Impact

Statements: Gulf of Mexico OCS Oil and Gas Lease Sales: 2007

- 2012 Final Environmental Impact Statement and the Gulf of Mexico Oil and Gas Leasing Program: 2012

- 2017 Final Programmatic Environmental Impact Statement

. This email is to confirm that the current Biological Assessment remains in place until a new Biological Assessment is issued.

Please contact EPA by March 6, 2013, if you do not concur.

Thank you.

Eva Land

-- Kyle BakerNOAA Fisheries Service

Protected Resources Division

o: 727

- 824

- 5312

f: 727

- 824

- 5309
ORIGIN BANK’S MOTION TO EXCLUDE

EXPERT TESTIMONY OF JASON KOONTZ Page 1

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

SALT AND LIGHT ENERGY §

EQUIPMENT, LLC, §

§

Plaintiff/Counter-Defendant, § Civil Action No.: 3:22-cv-00654-N

§

v. §

§

ORIGIN BANCORP, INC., DBA §

ORIGIN BANK, §

§

Defendant/Counter-Plaintiff, §

§

v. §

§

DENISE MUDIGERE and §

SHAWN MUDIGERE, §

§

Counter-Defendants. §

ORIGIN BANK’S MOTION TO EXCLUDE

EXPERT TESTIMONY OF JASON KOONTZ

Defendant/Counter-Plaintiff Origin Bancorp, Inc., d/b/a Origin Bank (“Origin”), by and 

through its undersigned counsel, respectfully moves to exclude the expert testimony of Jason 

Koontz under Federal Rules of Evidence 702 and 703. The grounds for this Motion are set forth 

in in greater detail in Origin’s accompanying Brief, which is being filed with this Motion.

Case 3:22-cv-00654-N Document 116 Filed 09/08/23 Page 1 of 2 PageID 2223
ORIGIN BANK’S MOTION TO EXCLUDE

EXPERT TESTIMONY OF JASON KOONTZ Page 2

Dated: September 8, 2023 Respectfully submitted,

/s/ Mazin A. Sbaiti

Mazin A. Sbaiti

Texas Bar No. 24058096

mas@sbaitilaw.com

Brad J. Robinson

Texas Bar No. 24058076

bjr@sbaitilaw.com

Griffin S. Rubin

Texas Bar No. 24121809

gsr@sbaitilaw.com

SBAITI & COMPANY PLLC

Dallas Arts Tower

2200 Ross Ave., Suite 4900W

Dallas, Texas 75201

T: (214) 432-2899

F: (214) 853-4367

ATTORNEYS FOR DEFENDANT

Case 3:22-cv-00654-N Document 116 Filed 09/08/23 Page 2 of 2 PageID 2224
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          FEB-28-2000
<PERIOD-START>                             MAR-01-1999
<PERIOD-END>                               NOV-30-1999
<CASH>                                           2,557
<SECURITIES>                                    80,000
<RECEIVABLES>                                   67,906
<ALLOWANCES>                                         0
<INVENTORY>                                     83,940
<CURRENT-ASSETS>                               298,540
<PP&E>                                         246,568
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 750,542
<CURRENT-LIABILITIES>                        4,937,159
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       119,706
<OTHER-SE>                                 (4,306,324)
<TOTAL-LIABILITY-AND-EQUITY>                   750,542
<SALES>                                      2,431,186
<TOTAL-REVENUES>                             2,431,186
<CGS>                                          256,736
<TOTAL-COSTS>                                2,843,461
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             118,200
<INCOME-PRETAX>                              (530,475)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (530,475)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (530,475)
<EPS-BASIC>                                     (0.14)
<EPS-DILUTED>                                   (0.14)


</TABLE>
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Merrill Lynch Preferred
Capital Trust III (the "Trust") and Merrill Lynch Preferred Funding III, L.P.
for the period ended December 26, 2003 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Linda L. Lowry,
Regular Trustee of the Trust, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d)
    of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
    respects, the financial condition and results of operations of the Trust.





                              MERRILL LYNCH PREFERRED CAPITAL TRUST III


                              By:  /s/ LINDA L. LOWRY
                                   ---------------------------------------------
                              Name:    Linda L. Lowry *
                              Title:   Regular Trustee









Dated: March 22, 2004
_____________________

* Linda L. Lowry functions as the equivalent of the Chief Executive Officer
  and Chief  Financial  Officer of the Trust for  purposes  of Section  906
  of the Sarbanes-Oxley Act of 2002.
Third District Court of Appeal

State of Florida 

Opinion filed June 12, 2024.

Not final until disposition of timely filed motion for rehearing.

________________

No. 3D23-1578

Lower Tribunal No. F16-6113C

________________

Angelo Johnson,

Appellant,

vs.

The State of Florida,

Appellee.

An appeal under Florida Rule of Appellate Procedure 9.141 (b)(2)

from the Circuit Court for Miami-Dade County, Lody Jean, Judge.

Daniel J. Tibbitt, P.A. and Daniel Tibbitt, for appellant.

Ashley Moody, Attorney General, and David Llanes, Assistant Attorney 

General, for appellee.

Before SCALES, LINDSEY, and MILLER, JJ. 

PER CURIAM.
2

Affirmed. See Cooper v. State, 712 So. 2d 1216, 1217 (Fla. 3d DCA 

1998), rev. denied, 720 So. 2d 518 (Fla. 1998) (“A suggestion that the 

defendant suborned perjury or that a defense witness manufactured 

evidence, without a foundation in the record, is completely improper.”); see 

also Calloway v. State, 210 So. 3d 1160, 1182 (Fla. 2017) (“[E]xperts may 

not comment on the credibility of other witnesses. This limitation is intended 

to minimize any effect that the expert status of the witness may have on the 

jury’s reception of the testimony.”) (internal citations omitted); White v. State, 

964 So. 2d 1278, 1286 (Fla. 2007) (“A defendant cannot establish ineffective 

assistance of counsel based on counsel’s failure to call a witness who is 

unavailable.”); Jacobson v. Humana Med. Plan, Inc., 636 So. 2d 120, 121 

(Fla. 3d DCA 1994) (“[T]he doctrine of the ‘law of the case[]’ . . . is that those 

points of law adjudicated in a former appeal are binding in order to promote 

stability of judicial decisions and to avoid piecemeal litigation.”); Deparvine 

v. State, 146 So. 3d 1071, 1088, 1095–96 (Fla. 2014) (finding trial counsel’s 

failure to develop evidence and cross-examine witness on issue did not 

“demonstrate deficient performance or prejudice” and was not ineffective 

because testimony would have little substance on outcome of case).
. BEFORE THE
DEPARTMENT OF TRANSPORTATION WASHINGTON, D.C.

__________________________________________ ) )
A pplication of ) ) OST- 20 13

- 0193
AE ROVIAS DE MEXICO, S.A. DE C.V. ) )
for renewal of exemption authority ) (Monterrey

- Chicago) ) __________________________________________)

APPLICATION OF AEROVIAS DE MEXICO, S.A. DE C.V.
FOR RENEWAL OF EXEMPTION

Communications with respect to this document should be sent to:

John R. Mietus, Jr.

L aw Office of John Mietus, LLC 6701 Democracy Blvd., Suite 300 Bethesda, MD 20817

- 7500 (202) 747

- 5212 john@mietuslaw.com

Counsel for AEROVIAS DE MEXICO,

S.A. DE C.V.

NOTICE: Any person may support or oppose this application by filing an answer and serving a copy of the answer on Aeromexico and upon persons served with this application no later than

D ecember 8 , 2014.

November 21, 2014BEFORE THE
DEPARTMENT OF TRANSPORTATION WASHINGTON, D.C.

__________________________________________ ) )
A pplication of ) ) OST- 20 13

- 0193
AE ROVIAS DE MEXICO, S.A. DE C.V. ) November 21, 2014 )
for renewal of exemption authority ) (Monterrey

- Chicago) ) __________________________________________)

APPLICATION OF AEROVIAS DE MEXICO, S.A. DE C.V.
FOR RENEWAL OF EXEMPTION

Pursuant to 49 U.S.C. § 40109(c), Aerovias de Mexico, S.A. de C.V.

(“Aeromexico”) respectfully request s renewal of the above

- captioned

exemption , granted by Notice of Action Taken dated November 26, 2013 , for

an additional, one

- year period. Among other things, t he Notice granted

Aeromexico an exemption to engage in scheduled foreign air transportation of

persons, property, and mail between Monterrey, Mexico and Chicago, Illinois.

Aeromexico intends to invoke the automatic extension provisions of 5 U.S.C.

§ 558(c) and Part 377 of the Department's Special Regulations. In support of

this application, Aeromexico states as follows:

1

. Aeromexico is a fla g carrier of the United Mexican States and

currently holds a permit, Order 91 -5- 25, and various exemptions which

authorize service between Mexico and numerous U.S. points. Aeromexico

provides extensive transborder service p ursuant to this authority

.
[Federal Register Volume 65, Number 215 (Monday, November 6, 2000)]
[Notices]
[Page 66565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-28430]


=======================================================================
-----------------------------------------------------------------------

MEDICARE PAYMENT ADVISORY COMMISSION


Commission Meeting

AGENCY: Medicare Payment Advisory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Commission will hold its next public meeting on Thursday, 
November 16, 2000, and Friday, November 17, 2000, at the Ronald Reagan 
Building, International Trade Center, 1300 Pennsylvania Avenue, NW, 
Washington, DC. The meeting is tentatively scheduled to begin at 10:00 
a.m on November 16, and at 9:00 a.m. on November 17.
    Topics for discussion include: draft report to Congress on risk 
adjustment; draft report to Congress on post-surgical recovery care 
centers; Medicare issues in rural areas including access to care; 
analysis of costs for hospital services in rural areas; coinsurance for 
hospital outpatient department services; updating Medicare payments for 
physician services; methods for determining payment adequacy and 
updates for hospital inpatient services; technology costs and hospital 
inpatient and outpatient services; and payments to skilled nursing 
facilities.
    Agendas will be mailed on November 7, 2000. The final agenda will 
be available on the Commission's website (www.MedPAC.gov)

ADDRESSES: MedPAC's address is: 1730 K Street, NW, Suite 800, 
Washington, DC 20006. The telephone number is (202) 653-7220.

FOR FURTHER INFORMATION CONTACT: Diane Ellison, Office Manager, (202) 
653-7220.

Murray N. Ross,
Executive Director.
[FR Doc. 00-28430 Filed 11-3-00; 8:45 am]
BILLING CODE 6820-BW-M
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS FOUND ON PAGES 1 THROUGH 3 OF THE COMPANY'S
FORM 10-Q FOR THE QUARTER AND YEAR-TO-DATE, AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                  1,000

<S>                           <C>
<PERIOD-TYPE>                 3-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-END>                               OCT-31-1999
<CASH>                                            1935
<SECURITIES>                                         0
<RECEIVABLES>                                    18088
<ALLOWANCES>                                       812
<INVENTORY>                                      59745
<CURRENT-ASSETS>                                 80814
<PP&E>                                           57898
<DEPRECIATION>                                   11605
<TOTAL-ASSETS>                                  130027
<CURRENT-LIABILITIES>                            96780
<BONDS>                                          11800
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             4
<OTHER-SE>                                       21443
<TOTAL-LIABILITY-AND-EQUITY>                    130027
<SALES>                                          42063
<TOTAL-REVENUES>                                 42063
<CGS>                                            37144
<TOTAL-COSTS>                                    37144
<OTHER-EXPENSES>                                  3458
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                1274
<INCOME-PRETAX>                                    187
<INCOME-TAX>                                        62
<INCOME-CONTINUING>                                125
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       125
<EPS-BASIC>                                       0.04
<EPS-DILUTED>                                     0.04


</TABLE>